✦ LIBER ✦

Reactivation of hepatitis B two years after rituximab therapy in a renal transplant patient with recurrent focal segmental glomerulosclerosis: a note of caution

✍ Scribed by Jan Gossmann; Ernst-Heinrich Scheuermann; Heinz-Georg Kachel; Helmut Geiger; Ingeborg A. Hauser

Book ID: 110890079
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 71 KB
Volume: 23
Category: Article
ISSN: 0902-0063
DOI: 10.1111/j.1399-0012.2008.00936.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abrogation of nephrotic proteinuria by r

Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis

✍ Jan Gossmann; Ernst-Heinrich Scheuermann; Stefan Porubsky; Heinz-Georg Kachel; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 656 KB

Loss of serum HBsAg after interferon-A t

Loss of serum HBsAg after interferon-A therapy in liver transplant patients with recurrent hepatitis-B infection

✍ Ben-Ari, Z ;Shmueli, D ;Shapira, Z ;Mor, E ;Tur-Kaspa, R 📂 Article 📅 1997 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 81 KB 👁 1 views

Reinfection with hepatitis B virus after orthotopic liver transplantation is nearly universal in patients who have not received posttransplant immunoprophylaxis. Recurrence almost invariably leads to chronic liver disease. Interferon has been used both prophylactically and therapeutically but has no